Company ProfilePremium

Green Circle Decarbonize Technology Limited

Company Profile Analysis

Ticker: GCDT

ESOMAR 23 Corporate BadgeISO Certifications Badge
Green Circle Decarbonize Technology Limited - Company showcase

Year Founded & Workforce

1992

3 Employees

Green Circle Decarbonize Technology Limited logo

Green Circle Decarbonize Technology Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Green Circle Decarbonize Technology Limited Overview

MetricFY2024FY2025FY2026
Employees (headcount)—43

Note: FY2025 figure from IPOScoop profile; FY2026 figure from Renaissance Capital/MoneyDJ/FXEmpire.

Green Circle Decarbonize Technology is a Hong Kong–based micro-cap engineering and materials company that commercializes proprietary phase change material (PCM) thermal energy storage (TES) technology developed by its founder over three decades. Its core assets are more than 20 PCM formulations spanning -86°C to +600°C, HDPE-encapsulated "BocaPCM-TES Panels," and an integrated "Ultra-High Efficiency Boca Hybrid Power Chiller Plant" with self-developed automatic controls that shift chiller load to off-peak tariff periods. The flagship reference installation at HAECO's Hong Kong International Airport headquarters is claimed to cut electricity use by at least 40% and running costs by roughly 50–70%. The business is tiny (FY2026 revenue HK$25.1M / ~US$3.2M), loss-making (FY2026 net loss HK$13.1M), and extremely concentrated (two customers ≈95% of revenue). Since its January 2026 IPO it has pivoted to an asset-light manufacturing model via SANVO Fine Chemicals, while financing itself through a highly dilutive note, warrant and equity-line package.


Company's own description (FY2026 20-F)

The company describes itself as a provider of advanced energy-saving solutions supported by proprietary phase change thermal energy storage materials and thermal engineering services. Its stated mission is to preserve the world through decarbonization technologies. By applying material science and nanotechnology, it developed PCM that temporarily stores surplus thermal energy for later use, bridging the timing gap between energy availability and demand. It encapsulates PCM in custom HDPE containers (BocaPCM-TES Panels), integrates these into a PCM-TES system, and deploys that system within central air-conditioning plants marketed as the Ultra-High Efficiency Boca Hybrid Power Chiller Plant, operated by a self-developed fully automatic control system.

Independent characterization

In substance, GCDT is a project-based building-services energy-efficiency contractor with an embedded specialty-materials IP core. Revenue is not driven by product volume; it is driven by a handful of large, lumpy engineering contracts (lump-sum chiller-plant and MVAC installations) plus one long-running energy performance contract (EPC/"PBC model") at HAECO. The company manufactures PCM in-house in small quantities but buys all heavy plant (chillers, refrigeration units, cooling towers, pumps) and subcontracts installation. It is therefore closer to a niche ESCO (energy service company) and design-build integrator than to a materials manufacturer. Gross margins have compressed from 54% (FY2022) to 17% (FY2026) as revenue mix has shifted from performance-based savings income toward pass-through construction work.

Revenue model

Revenue streamDescriptionContract formMargin character
Energy saving service incomePerformance-based contracts (PBC): company funds and installs the system, customer pays a share of realized energy savings over the contract term. Principal example: HAECOMulti-year, performance-linkedRecurring, but capital-intensive up front (debt-funded)
Construction service incomeLump-sum fixed-price supply-and-install of BocaPCM-TES systems / chiller plants / MVAC worksOne-off projectLow margin; high pass-through of equipment and subcontract cost
Consultancy service incomeR&D consultancy (e.g., SOAR Equipment Rental project, FY2025)One-offVariable
Project-related services (stated)Project management, commissioning, operations & maintenance, remote monitoringAncillary—
Product sales (PCM / panels)Panels sold via agents; future China mass production via SANVOProductNot separately reported in reviewed materials

The mix by product vs. service vs. subscription vs. licensing is not formally disclosed. Based on customer-level disclosure, FY2026 revenue was approximately half performance-contract/service income linked to HAECO and half construction income (Macau hospital and Bayview Garden). There is no material licensing or subscription revenue disclosed.

Value-chain position

Value-chain stageGCDT role
Raw materials (chemicals, nanomaterials)Buyer; single German nanomaterial supplier, order-by-order, no long-term contract
PCM formulationIn-house (core IP)
Panel encapsulationIn-house historically; China mass production outsourced to SANVO from September 2026
Heavy HVAC equipmentBuyer (chillers, cooling towers, pumps from third parties)
System design & controlsIn-house (automatic control software developed 2015; AI/MPC upgrade in development)
InstallationSubcontracted
Financing of customer projectsCompany-funded via debt/equity under PBC model
Distribution outside Hong KongFive local agents (Hong Kong, Shanghai, Guangdong, Korea, Dubai) on two-year agreements

Customer types and end-markets

Customers disclosed to date are institutional/commercial building owners and operators: aviation MRO (HAECO), healthcare (Macau University of Science and Technology Foundation – University Hospital), retail property (Bayview Garden Shopping Centre via LMP International Limited), and equipment rental/industrial (SOAR Equipment Rental Company Limited, consultancy). Targeted end-markets per the prospectus include commercial and public buildings, cold chain/biobank storage (with Gene Company Limited), data-center liquid cooling, and solar-thermal domestic heating.

Strategy

Stated strategy (IPO prospectus / 20-F themes)

  1. Substantial reliance on the PBC (performance-based contract) model, with the added aim of helping clients earn carbon credits for sale in carbon markets.

  2. Strategic alliances and solicitation with NGOs, green funds and companies with decarbonization targets or high electricity consumption.

  3. Continuous innovation: cold chain (GeneHK), data-center liquid cooling, AI/model-predictive control, solar-thermal domestic heating.

  4. Expansion of project-related services (project management, commissioning, O&M), including certifying third-party service providers.

  5. Arrangement of project financing with banks and financial institutions for customers.

  6. Mass production of BocaPCM-TES Panels — originally via an own factory in the PRC; now via SANVO.

Initiatives in the last 24 months

InitiativeDateDetailStatus
Bayview Garden MVAC/TES contractAug 2024HK$12.999M lump sumLargely recognized FY2025–FY2026
Macau hospital chiller plantMar 2025HK$14.0M lump sum incl. BocaAI ControlsCompleted May 2026
IPO and listingJan–Feb 2026US$11.5M grossCompleted
Production capacity plan (factory)IPO use of proceeds46.8% of net proceeds earmarkedApparently superseded by SANVO outsourcing
CFO successionApr–Jun 2026Leung appointedCompleted
July 2026 financingJul 2026US$10M OID note, 29.1M warrants at US$2.00, US$100M equity line (Target Capital 1)First tranche funded; further tranches conditional
Governance recapitalizationAug 20265bn authorized shares; dual class; consolidationEffective
SANVO manufacturing partnershipSep 2026Sole supplier/exclusive manufacturer in PRC; 3-year initial term with automatic 3-year renewalsFramework; formal operational agreements to follow
NYSE American complianceSep–Oct 20261-for-6 consolidationEffective 7 Oct 2026

Medium-term targets and guidance

The company has not issued quantitative revenue, margin or profitability guidance. The 20-F contains a qualitative statement that management expects sufficient funds for twelve months.

Products & Services

All products sit within the single energy-saving solutions business.

Product Portfolio

#Product / serviceDescription & key capabilitiesTarget customerLaunch / versionPricing model
1

BocaPCM (PCM formulations)

20+ proprietary PCM types, each with a distinct phase-change temperature and TES capacity; operating range -86°C to +600°C. Flagship +8°C PCM (1992) optimized for chilled-water air conditioning; +58°C PCM for solar-thermal heat storage

HVAC, refrigeration, heating integrators

1992 onward

—
2

BocaPCM-TES Panel

Custom HDPE plastic container fully filled with PCM solution; ultrasonic-welded design (2013) to enhance heat transfer. Third-generation encapsulation after steel balls (2003) and first HDPE panels (2007)

HVAC/refrigeration systems; agents

2007 (HDPE), 2013 (ultrasonic)

Not disclosed; China mass production via SANVO from 2026

3

BocaPCM-TES System / tanks

Thermal energy storage system built from panels, installed in tanks within central chilled-water plants; stores surplus cooling when chiller output exceeds load and releases it when load exceeds output; acts as standby capacity on equipment failure

Building owners

—

Lump-sum or PBC

4

Ultra-High Efficiency Boca Hybrid Power Chiller Plant

Integrated chiller plant combining third-party chillers/cooling towers with BocaPCM-TES and automatic controls; shifts load to off-peak tariff periods via real-time demand peak management; claimed ≥40% electricity reduction and ~50–70% running-cost reduction (HAECO reference); patent applications filed in the US and PRC

Commercial, institutional, airport, hospital buildings

Plant concept in operation at HAECO; latest version 2025–26 (Macau)

Lump-sum (e.g., HK$14.0M Macau) or performance-based

5

Fully automatic control system / "BocaAI Controls"

Self-developed control software (2015) optimizing chiller COP and charge/discharge scheduling; model predictive control (MPC) / self-learning AI upgrade in development

Bundled with plant

2015; AI version in development (BocaAI named in Macau scope)

Bundled

6

Energy performance contracting (PBC model)

Company funds equipment and installation; customer pays a portion of realized energy savings over the term; company also positions customers to earn carbon credits

Large-load building owners

—

Savings share

7

Construction / MVAC installation services

Supply and installation of complete mechanical ventilation and air conditioning (MVAC) including BocaPCM-TES (e.g., Bayview Garden, ~50,000 sq ft GFA)

Property owners, contractors

Aug 2024 contract

Lump-sum fixed price (HK$12.999M)

8

Consultancy (R&D services)

R&D consultation (SOAR Project)

Industrial clients

FY2025

Fee

9

Project management, commissioning, O&M

End-to-end project management; performance commissioning; remote monitoring and periodic onsite maintenance

Installed-base customers

Ongoing

—
10

Cold chain / biobank products (development)

With Gene Company Limited (GeneHK): ultra-low-temperature transport boxes and freezer backup systems; exclusive supply in Mainland China, HK, Macau, Taiwan for research, medical, diagnostic, pharma, life sciences, biotech

Labs, biobanks, pharma

Development

Product development & supply agreement

11

Dual-circuit liquid cooling for data centers (development)

Combines refrigeration-based basic cooling with direct/immersion liquid cooling to reduce operating cost and noise; negotiations with a major Hong Kong bank disclosed in prospectus

Data centers

Development

—
12

Domestic heating system (development)

+58°C PCM combined with vacuum-tube solar collectors for underfloor/domestic heating; company has stated intent to acquire a vacuum-tube collector manufacturer (no target named)

Residential

Development

—

“—” = not publicly disclosed.

Financial Narrative

All figures HKD thousand unless stated; source F-1 (FY2022–FY2023, audited by BF Borgers) and FY2026 20-F (FY2024–FY2026, audited by ZH CPA). Ratios derived by the analyst.

Per-share data

Notes: The pre-IPO share count was 10,000,000 (per prospectus). FY2022 share count is uncertain given 2022 reorganization subscriptions. Interim cross-check: H1 FY2026 loss per share HK$0.23 on HK$2.3M net loss (consistent with 10M shares). Basic and diluted are identical (loss-making; anti-dilutive instruments).

Margins and growth

Revenue CAGR FY2022–FY2026 (derived): (25,051 / 6,868)^(1/4) − 1 ≈ 38.2%. FY2024–FY2026 two-year CAGR ≈ 118.7%.

Interim (half-year) results

Source: F-1 (2024) for H1 FY2023/FY2024; 6-K furnished 6 Feb 2026 (via StockTitan summary) for H1 FY2025/FY2026 (rounded to HK$0.1M).

Income statement commentary

Scale and volatility. Revenue is a function of one or two contracts per year. FY2024 (HK$5.2M) was entirely HAECO savings income; FY2025 (HK$16.6M) added the Bayview Garden construction contract (HK$8.5M recognized) and the SOAR consultancy (HK$3.0M); FY2026 (HK$25.1M) was driven by the Macau hospital project (≈HK$11.7M recognized) and a step-up in HAECO income. Absent new lump-sum awards, FY2027 revenue will fall back toward recurring HAECO income because the Macau project completed in May 2026 and Bayview Garden is substantially recognized.

Margin compression is structural, not cyclical. Gross margin fell every year from 54.0% (FY2022) to 17.3% (FY2026). The drivers are mix: performance-contract savings income (high gross margin once the plant is depreciated) has been diluted by construction contracts in which chillers, cooling towers and subcontracted labor are passed through at thin markups. The business is growing revenue by becoming more of a contractor.

Operating losses persist at every revenue level. Operating loss widened to HK$6.8M in FY2026 despite record gross profit, reflecting public-company costs (listing, legal, audit, D&O insurance) layered on a very small cost base.

Below-the-line charges tripled in FY2026. The gap between operating loss and pre-tax loss rose from ~HK$2.1–2.6M (FY2022–FY2025) to HK$6.3M in FY2026. This should be verified in the 20-F notes.

No tax shield. Small tax credits in FY2022–FY2023 ceased; no deferred tax asset recognition is evident from reported figures.

Balance sheet

The latest verified balance sheet is the pre-IPO interim at 30 September 2025.

Source: 6-K interim report (StockTitan summary). Seeking Alpha shows "Q4 2025" total assets US$3.46M and total liabilities US$6.45M, consistent with these HKD figures at HK$7.80.

Borrowings at 31 March 2026 (partial, from 20-F XBRL):

Aggregator data (flagged): Benzinga displays TTM operating cash flow -15.52M, investing -8.58M (capex), financing +59.03M, net change in cash +34.92M, total debt 29.79M and total cash 258.3K, labelled "$". The cash-flow figures are internally consistent and appear to be FY2026 HKD amounts mislabelled as USD; the "total cash 258.3K" figure is inconsistent with a +HK$34.9M net cash increase and likely relates to a different period or entity-level figure. These should not be relied upon without the 20-F statements.

Cash flow (verified items only)

capex -8580; FCF -24100; financing +59030.

Ratios

Commentary: Most ratios are not meaningful or not computable from verified data. Equity was negative pre-IPO (HK$-23.3M at 30 Sep 2025), so ROE and debt/equity were undefined; EBITDA is negative or undisclosed, so leverage and coverage ratios are not meaningful. On an annualized H1 FY2026 basis, asset turnover was roughly 0.9x (HK$23.6M annualized revenue / HK$26.9M assets) — indicative only. The 20-F states management believes it has sufficient funds for twelve months from the report date, a materially more benign statement than the explicit going-concern uncertainty disclosed at 30 September 2025 and 31 March 2025; that improvement is attributable to IPO proceeds and the July 2026 financing.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityJurisdictionOwnershipRole

Green Circle Decarbonize Technology Limited

Cayman Islands

Listed holdco

Holding company; no substantive operations

Boca International Limited

Hong Kong

100%

Sole operating subsidiary (R&D, PCM production, projects)

Joyful Star Limited

(Chan vehicle)

Shareholder

Holds 5,280,000 pre-consolidation shares (now Class B)

Green Circle Limited

(Chan vehicle)

Shareholder

Holds 1,080,000 pre-consolidation shares (now Class B)

Customer (HKD K, derived = % × total revenue)

Customer (HKD K, derived = % × total revenue)FY2024FY2025FY2026

HAECO (energy saving service; HKIA chiller plant)

5,2365,07912,142

Macau Univ. of Science & Technology Fdn – University Hospital (construction)

0011,747

LMP International – Bayview Garden (construction)

08,4961,162

SOAR Equipment Rental (consultancy)

03,0000

Total revenue

5,23616,57525,051

Customer share of revenue (%)

Customer share of revenue (%)FY2024FY2025FY2026

HAECO

100.0030.6448.47

Macau University Hospital

0.000.0046.89

LMP International

0.0051.264.64

SOAR Equipment Rental

0.0018.100.00

Income Statement

Metric (HKD K)FY2022FY2023FY2024FY2025FY2026

Revenue

6,8686,5875,23616,57525,051

Cost of revenue

-3,159-4,111-3,791-12,824-20,706

Gross profit (derived)

3,7092,4751,4453,7514,345

Operating loss

-322-2,942-5,657-3,917-6,834

Non-operating items incl. finance costs (derived: LBT − operating loss)

-2,560-2,051-2,265-2,066-6,280

Loss before tax

-2,882-4,993-7,922-5,982-13,113

Income tax credit (derived)

130506000

Net loss (loss & total comprehensive loss)

-2,752-4,487-7,922-5,982-13,113

Dividends per share

00000

Per-Share Data

Metric (HKD)FY2023FY2024FY2025

Loss per share, derived (net loss ÷ 10,000,000 pre-IPO shares)

-0.45-0.79-0.60

Margin Analysis (%)

Metric (%)FY2022FY2023FY2024FY2025FY2026

Revenue growth YoY

—-4.1-20.5216.551.1

Gross margin

54.037.627.622.617.3

Operating margin

-4.7-44.7-108.0-23.6-27.3

Net margin

-40.1-68.1-151.3-36.1-52.3

Financial Analysis

MetricFY2026 (USD K)

Revenue

3,212

Gross profit

557

Operating loss

-876

Net loss

-1,681

Income Statement (Half-Yearly)

Metric (HKD K)H1 FY2023 (6m to 30 Sep 2022)H1 FY2024 (6m to 30 Sep 2023)H1 FY2025 (6m to 30 Sep 2024)H1 FY2026 (6m to 30 Sep 2025)

Revenue

2,7092,1074,80011,800

Gross profit

———2,800

Operating loss

-2,087-2,152-1,900-1,000

Net loss

-2,765-2,929-2,800-2,300

Balance Sheet Item Details

Balance sheet item (HKD K)30 Sep 2025

Total assets

26,900

Total liabilities

50,200

Shareholders' equity (deficit)

-23,300

Cash and equivalents

1,100

Bank and other borrowings

31,800

Net debt (derived: borrowings − cash)

30,700

Working capital

-39,200

Goodwill & intangibles

0

Financial Analysis — IPO gross proceeds

ItemAmountDate

IPO gross proceeds

US$10.0M (net ≈ US$8.57M)

14 Jan 2026

Over-allotment gross proceeds

US$1.5M

12 Feb 2026

Founders' loan settled

HK$4.6M outstanding balance settled post-IPO

After 14 Jan 2026

Loan 2 principal repaid

HK$6,618,280

Jan–Mar 2026

Loan 8 (bank) drawn

HK$2,500,000 at 6.25%

14 Jan 2026

July 2026 note first installment

US$2.0M cash received (US$10.0M face note issued; OID 20%)

24 Jul 2026

Equity purchase agreement initial sale

US$1.0M (676,205 shares + 1,143,962 pre-funded warrants)

24 Jul 2026

Loan Details

LoanPrincipal (HKD)RateInceptionMaturity / security

Loan 5 (other borrowing)

990,0005.00%

4 Sep 2018

On demand; unsecured

Loan 6 (bank)

1,004,400—

7 Sep 2021

—

Loan 7 (bank)

3,000,000—

21 May 2025

—

Loan 8 (bank)

2,500,0006.25%

14 Jan 2026

—

Loans 1–4

———

Loan 2 had a 12-year repayment term; HK$6.62M repaid in Q4 FY2026

Cash flow item (HKD K)

Cash flow item (HKD K)FY2022FY2023FY2024FY2025FY2026

Dividends paid

00000

Share buybacks

00000

Region revenue (HKD K, derived)

Region revenue (HKD K, derived)FY2024FY2025FY2026

Hong Kong

5,23616,57513,304

Macau

0011,747

Mainland China

000

Rest of world

000

Region growth YoY (%)

Region growth YoY (%)FY2025FY2026

Hong Kong

216.5-19.7

Share Price History

DatePrice (USD)Note

12 Jan 2026

4.00

IPO price

13 Jan 2026

~4.21

First-day return +5.3%

Jan–Feb 2026

5.85

52-week high

9 Feb 2026

4.30

Market cap ~US$53.7M

27 Feb 2026

1.92

-23.2% day

23 Mar 2026

0.87—

6 Apr 2026

1.24—

26 May 2026

0.75—

31 Aug 2026

0.41

Market cap ~US$7.9M

9 Sep 2026

0.64

Post-SANVO spike then -29.9% day

Early Oct 2026

0.37–0.40

Pre-consolidation; market cap ~US$4.8–5.4M

52-week low

0.33—

Return metric (%)

Value

—

Since IPO (to ~US$0.37 pre-split)

-90.7—

1-year

n/a (listed Jan 2026)

—

Shares outstanding (thousand)

Shares outstanding (thousand)FY2025FY2026Aug 2026Post-consolidation (derived)

Total ordinary shares

10,00012,87513,5512,259

Class B shares

006,3601,060

Capital Instruments

InstrumentQuantity / sizeKey terms

July 2026 Warrants

Up to 29,122,679 shares

Initial exercise US$2.00; full-ratchet anti-dilution to floor; six-monthly price resets; automatic cashless exercise at expiry; Black-Scholes repurchase right on fundamental transactions

July 2026 Pre-Funded Warrants

1,143,962 shares

Exercise US$0.001

July 2026 Note

US$10.0M face; US$8.0M subscription in 3 installments (US$2.0M paid; US$0.5M on resale registration filing; US$5.5M on effectiveness)

20% OID; no interest until maturity 16 Jan 2027; convertible at greater of US$0.1099 floor and 80% of lowest close in prior 5 trading days; prepayable at 110%; holder may require up to 50% of new raise proceeds for repayment

Equity Purchase Agreement

Up to US$100.0M

Investor purchases at prices set by agreement; plus up to US$2.0M commitment shares

Underwriters' Warrants

62,500 shares each to representative and co-manager

Exercise US$4.00; exercisable 30 Sep 2026 – 30 Sep 2029

Valuation Multiples

MultipleGCDTBasis

P/E

n/m

Loss-making

EV/EBITDA

n/m

Negative/undisclosed EBITDA

P/S

~1.4–2.1x

Aggregator (Benzinga) range Aug–Sep 2026; ~1.6x derived from ~US$5M market cap / US$3.2M FY2026 revenue

P/B

~1.1–1.8x (aggregator)

Book value/share US$0.36 per Benzinga

Capital Markets

ItemStatus

Analyst consensus / price targets

None (no coverage; Yahoo shows no 1-year target)

Dividend history / policy

Never paid; no intention to pay in foreseeable future; HK subsidiary has accumulated deficit preventing distributions

Buyback authorizations

None (other than technical repurchases for Class B swap)

Credit ratings (Moody's / S&P / Fitch)

Not rated

Short interest

~2.5% (Benzinga)

Analyst Conclusions

Guidance and consensus

Management has provided no quantitative guidance. There is no sell-side coverage and no consensus. The only forward-looking financial statement is the 20-F's assertion of sufficient liquidity for twelve months, which depends on continued funding under the July 2026 note and equity line.

Bull case

  1. Validated technology with real economics: a multi-year HAECO operating record and completed Macau hospital project provide referenceable proof of ≥40% energy savings, which is a compelling value proposition for high cooling-load buildings in subtropical Asia.

  2. Asset-light scale-up: SANVO's manufacturing platform could allow panel volume growth in China without the factory capex the company could never have funded, while GCDT keeps the formulation IP and design role.

  3. Optionality in adjacent markets: data-center liquid cooling and cold-chain/biobank storage (with exclusive GeneHK arrangements) are structurally growing markets where even small wins would be material against a ~US$3M revenue base and ~US$5M market cap.

Bear case

  1. Dilution overwhelms fundamentals: the warrant package alone (29.1M shares pre-consolidation) exceeds twice the shares outstanding, with full-ratchet and periodic reset features, convertible debt priced at a discount to recent lows, and a US$100M equity line — a classic structure that tends to transfer value from common holders to the financier.

  2. Revenue cliff and concentration: with Macau completed (May 2026) and Bayview Garden substantially recognized, FY2027 revenue could revert toward the HAECO run-rate absent new lump-sum contracts; two customers were ~95% of FY2026 revenue and losses doubled to HK$13.1M even at record revenue.

  3. Governance and execution capacity: a 3–4 person company with founder-owned IP, a dual-class structure giving ~98% voting control, CFO turnover post-IPO, and no granted patents is poorly equipped to execute a multi-market expansion, and minority holders have little recourse.

Catalysts and monitorables (next 12 months)

TimingCatalyst / monitorable
Q4 2026Post-consolidation price stability and NYSE American compliance status
Q4 2026Effectiveness of resale F-1 (triggers US$5.5M third note installment)
Q4 2026 – Q1 2027Interim results for six months to 30 Sep 2026 (6-K): revenue run-rate post-Macau, cash, debt
16 Jan 2027July 2026 Note maturity — repayment, conversion or extension
~Jan 2027First six-monthly warrant exercise price reset (six months after 24 Jul 2026 issuance)
OngoingEquity-line drawdowns and share count growth
OngoingFormal SANVO operating agreements; first PRC panel orders
OngoingNew lump-sum or PBC contract awards; any data-center or GeneHK commercial orders
OngoingPatent grants (US/PRC) and assignment of founder-owned trademark to the company
Mid-2027FY2027 20-F (due by ~31 Jul 2027)

Analyst verdict

Green Circle Decarbonize Technology is a genuine but sub-scale engineering business wrapped in an unattractive public-equity structure. The underlying proposition — PCM thermal storage that lets chiller plants run at peak efficiency and shift load to cheap off-peak hours — is technically sound and commercially proven at a small number of high-profile Hong Kong and Macau sites. Revenue has grown at a ~38% CAGR since FY2022 and reached HK$25.1M in FY2026. Those are the positives, and they are real.

The problems are larger. First, the growth is lumpy, contractor-style revenue: gross margins have halved since FY2022, operating losses persist at every scale, and two customers accounted for ~95% of FY2026 revenue. Second, the company emerged from its IPO having raised only US$11.5M against a pre-IPO equity deficit of HK$23.3M and borrowings of HK$31.8M; within six months it resorted to an original-issue-discount convertible note, a 29-million-share full-ratchet warrant and a US$100M equity line — instruments whose economics favour the financier over common shareholders. Third, the August 2026 dual-class recapitalization has locked in near-total founder voting control just as minority holders face heavy dilution. The share price (down ~90% from the IPO in nine months, requiring a 1-for-6 consolidation) reflects these realities.

The SANVO partnership is the most constructive development: it replaces an unfundable factory plan with an asset-light route into China. If it produces measurable panel volumes and the company converts its data-center and cold-chain pipeline into orders, the equity has optionality. Until then, the investment case rests on execution by a three-to-four person team under a financing structure that will likely keep expanding the share count.

Verdict: Speculative / high-risk. Fundamental interest only for investors able to underwrite total loss; monitor note maturity (16 Jan 2027), warrant resets, SANVO volumes and new contract awards before any constructive reassessment.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleTenureBackgroundEducationCompensation (latest)

Dr. Chan Kam Biu Richard

Chief Executive Officer; Executive Director; controlling shareholder

Founder 1992; MD of Boca since Jun 1995; holdco director pre-IPO

40+ years in electrical & mechanical engineering and construction project management; Senior Project Engineer, Hutchison Whampoa Properties (1989–1995); member, Hong Kong Invention Association (2022)

Higher diploma in mechanical engineering, Hong Kong Polytechnic; master's and doctorate in business administration, Newport University

—

Ms. Lui Lai Yuen

Chief Administrative Officer; Executive Director

From IPO effectiveness (Jan 2026)

Related-party balances with the company disclosed in 20-F XBRL

Bachelor's in business administration, La Jolla University (San Diego)

NPD

Mr. Louis Ho Ming Leung

Chief Financial Officer

Since 8 Jun 2026

10+ years in accounting, financing and auditing; INED of GR Life Style Co., Future Data Group and Mabpharm; company secretary of Shanghai XNG Holdings (since May 2026); FC & company secretary, Basic House New Life Group (2019–2022); CFO, Prosperous Future Holdings (2017–2019)

Bachelor's in Quantitative Finance, Chinese University of Hong Kong; HKICPA member since 2008

NPD

Mr. Lai Tai Yan

Former CFO

Pre-IPO service agreement – resigned 15 Apr 2026

No disagreement stated

NPD

NPD

Chan Sze Man

Independent Non-Executive Director

From IPO

Named in IPO prospectus

NPD

NPD

(Name not captured)

Independent Non-Executive Director

From IPO

Chairman of Sun Innovation Holdings (now Digital Domain Holdings, HKEX: 547) from 2003 to 2009

NPD

NPD

Other INED(s)

Independent Non-Executive Director(s)

From IPO

Earlier DRS (2023) named nominees Michele Takis Matsuda, Hui Ringo Wing Kun and Yuen Sau Ying Christine; final board composition at IPO could not be fully verified

NPD

NPD

Governance Overview

AttributeStatus

Board size

Approx. 5 (2 executive + ~3 independent), not fully verified

Controlled company

Prospectus: controlled company while Chan holds >50%; company stated it did not intend to rely on exemptions unless it ceases to be an FPI. Economic stake fell to 46.93% (Aug 2026), but voting control is now overwhelming via Class B shares

Dual-class

Approved 10 Aug 2026: Class B = 50 votes/share; 6,360,000 Class B (pre-consolidation) held by Joyful Star (5,280,000) and Green Circle Limited (1,080,000) = 318,000,000 votes

Implied voting control (derived)

318,000,000 / (318,000,000 + 7,191,205 Class A votes) ≈ 97.8%

Key-person IP dependence

Trademark and domain name owned personally by Mr. Chan and licensed to the company

Major Shareholders

HolderShares (pre-consolidation)% of 13,551,205 outstanding (9 Aug 2026)Notes

Dr. Chan Kam Biu Richard (via Joyful Star Ltd and Green Circle Ltd)

6,360,00046.93

Converted to Class B (50 votes)

Wong C Ching (via Wong Tan Suen)

360,0002.66

Founding partner subscription 2022

Ma Chi Heng

240,0001.77

Founding partner subscription 2022

Target Capital 1, LLC

676,205 + 1,143,962 pre-funded warrants

4.99 (shares only)

July 2026 investor; plus 29.1M warrants and US$10M convertible note

Public float (Class A, ex-insiders)

≈7.19M Class A incl. above

—

StockTitan float 7.19M

Competitive Landscape

Key Competitors

#CompetitorSegment overlapRelative positioning vs GCDT
1

Trane Technologies (CALMAC ice storage)

Ice-based TES for chilled-water plants

Global leader in ice TES with large installed base and channel; GCDT's PCM at +8°C avoids low-temperature chillers required for ice

2

Baltimore Aircoil Company (Ice Chiller TES)

Ice TES, cooling towers

Established OEM; also a potential equipment supplier

3

EVAPCO (ice TES)

Ice TES, evaporative cooling

Established OEM

4

Carrier / CIAT (Cristopia encapsulated PCM nodules)

Encapsulated PCM/ice-ball TES

Directly analogous encapsulated-storage approach with global distribution

5

PCM Products Ltd (UK, PlusICE)

PCM formulations and encapsulation for HVAC TES

Closest product analogue; broader temperature range catalogue

6

Rubitherm Technologies (Germany)

PCM materials

Specialist PCM supplier

7

Croda (CrodaTherm bio-based PCMs)

PCM materials

Chemical major with bio-based PCM line

8

Viking Cold Solutions (US)

PCM TES for cold storage/refrigeration

Competes in cold-chain applications GCDT targets

9

Pluss Advanced Technologies (India)

PCM materials and cold-chain products

Asian PCM competitor in cold chain

10

Sunamp (UK)

PCM heat batteries for domestic heating

Competes with GCDT's planned +58°C heating product

11

Hong Kong ESCOs and E&M contractors (e.g., large building-services contractors and utility-affiliated energy services)

Building retrofit, chiller optimization, EPCs

Local incumbents with balance sheets to fund performance contracts

12

Data-center liquid/immersion cooling specialists (e.g., GRC, LiquidStack, Submer)

Immersion cooling

Far ahead in a market GCDT has only begun to design for

Peer Comparison FY2026

MetricGCDT (FY2026)PCM Products Ltd

Revenue

HK$25.1M (~US$3.2M)

Private; NPD

Revenue growth

+51.1%

NPD

Gross margin

17.3%

NPD

Operating margin

-27.3%

NPD

R&D intensity

NPD

NPD

Company Snapshot

$3.2M

Revenue

3

Employees

$4.8M

Market Cap

1992

Founded

Kowloon, Hong Kong

Headquarters

SWOT Analysis

Strengths

  • Long-lived reference installation: HAECO's HKIA headquarters plant underpins the claim of ≥40% electricity reduction and ~50–70% running-cost savings (FY2026 20-F).
  • Proprietary materials portfolio: 20+ PCM formulations spanning -86°C to +600°C (20-F), giving breadth for HVAC, cold chain and heating.
  • Integrated offering: PCM + panels + controls + plant design in one package; control software since 2015 and "BocaAI Controls" scope in the Macau contract.
  • Demonstrated ability to win sizeable contracts relative to scale: HK$12.999M (Bayview Garden, Aug 2024) and HK$14.0M (Macau hospital, Mar 2025), each roughly equal to or greater than a full prior year's revenue.
  • Revenue growth: FY2022–FY2026 revenue CAGR ≈38.2%; FY2026 +51.1% to HK$25.1M.
  • Asset-light manufacturing route: SANVO (HKEX-listed) appointed exclusive PRC manufacturer, avoiding factory capex originally budgeted at 46.8% of IPO net proceeds.

Weaknesses

  • Extreme customer concentration: HAECO 48.47% and Macau hospital 46.89% of FY2026 revenue (20-F).
  • Persistent and widening losses: net loss HK$13.1M in FY2026 vs HK$6.0M in FY2025; operating losses in every year FY2022–FY2026.
  • Margin erosion: gross margin fell from 54.0% (FY2022) to 17.3% (FY2026).
  • Thin organization: 3–4 employees reported; management acknowledges lack of public-company experience; CFO turnover within 3 months of IPO (resignation 15 Apr 2026).
  • Weak IP protection: patents only applied for (US, PRC); trademark and domain owned personally by the CEO and licensed.
  • Stretched pre-IPO balance sheet: equity deficit HK$23.3M, borrowings HK$31.8M, negative working capital HK$39.2M at 30 Sep 2025, with explicit going-concern doubt.

Opportunities

  • PRC scale-up via SANVO: 3-year exclusive manufacturing partnership with automatic renewals; 20-F expects substantial future growth from the PRC.
  • Data-center cooling: dual-circuit liquid-cooling design and disclosed negotiations with a major Hong Kong bank.
  • Cold chain/biobanking: exclusive Greater China supply arrangement with GeneHK across research, medical and pharma sectors.
  • Carbon credits: strategy to help PBC clients earn and sell carbon credits, potentially enhancing contract economics.
  • Hong Kong policy tailwinds: EERSB accelerated tax deductions for registered energy-efficient installations.
  • Repeat business from completed references: Macau hospital completion (May 2026) creates a healthcare reference in a new territory.

Threats

  • Massive dilution: up to 29,122,679 warrants (full-ratchet, six-monthly resets), US$10M convertible note (conversion at 80% of recent low, floor US$0.1099 pre-consolidation) and a US$100M equity line, versus 13.55M shares outstanding pre-consolidation.
  • Listing risk: stock fell ~90% from the US$4.00 IPO price; 1-for-6 consolidation needed to support NYSE American compliance.
  • Supply-chain single points of failure: single German nanomaterial supplier (order-by-order), and now a single PRC manufacturer.
  • Financing dependency: PBC model requires company-funded upfront capex; note matures 16 Jan 2027 and holder may demand up to 50% of new capital-raise proceeds at 110% of principal.
  • Governance discount: dual-class structure gives Class B ~97.8% of votes (derived); some institutional investors and index providers avoid such structures (20-F).
  • Regulatory/geopolitical: HFCAA, CSRC Trial Measures and broader scrutiny of Hong Kong/China-linked U.S. listings (20-F risk factors).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
21 May 2025HK$3.0M bank loan drawn (Loan 7)Pre-IPO liquidity bridge
FY2025 close (31 Mar 2025)Going-concern doubt disclosed in prospectusHighlighted pre-IPO fragility
Sep 2025 (H1 FY2026)Revenue HK$11.8M (vs HK$4.8M); net loss narrowed to HK$2.3M; equity deficit HK$23.3MGrowth but stretched balance sheet
28 Nov 2025F-1/A Amendment No. 14 filedProtracted ~2-year registration process
12 Jan 2026IPO priced at US$4.00 (valuation ~US$50M at pricing)Listing achieved
13 Jan 2026First trade on NYSE American; first-day return +5.3%—
14 Jan 2026IPO closed (US$10.0M gross); new HK$2.5M bank loanRecapitalization
Jan–Mar 2026HK$6.62M Loan 2 principal repaidDeleveraging using proceeds
6 Feb 2026Interim results 6-K furnishedFirst public-company report
12 Feb 2026Over-allotment exercised (US$1.5M)Total US$11.5M gross
Feb 2026Stock trades ~US$3.70–4.30; 52-week high US$5.85Post-IPO peak period
27 Feb 2026Stock falls 23% to US$1.92 in one sessionSharp de-rating begins
23 Mar 2026Stock ~US$0.87Below US$1 within ~10 weeks of IPO
15 Apr 2026CFO Lai Tai Yan resignsFinance leadership gap
May 2026Macau hospital chiller plant completedKey reference project delivered
26–29 May 2026Stock trades US$0.75–1.04Persistent sub-US$1 pricing
8 Jun 2026Louis Ho Ming Leung appointed CFORestores finance leadership
16 Jul 2026Financing agreements signed (US$10M note, warrants, US$100M equity line); 6-K/A adds omitted exhibitsHighly dilutive capital structure
24 Jul 2026First tranche closed: US$2.0M gross; 676,205 shares and 1,143,962 pre-funded warrants issuedCash runway extended modestly
27 Jul 2026EGM materials published (dual-class charter)Governance change
10 Aug 2026EGM approves capital increase, dual class, consolidation; Form D notices filedFounder voting lock-in
14 Aug 2026FY2026 20-F filed: revenue HK$25.1M (+51.1%), net loss HK$13.1MLosses more than doubled
18 Aug 2026Class B share swap with Joyful Star and Green Circle Ltd completed~97.8% voting control (derived)
31 Aug 2026Stock ~US$0.41; market cap ~US$7.9M—
4–8 Sep 2026SANVO partnership announced; stock +146% on announcement dayAsset-light pivot; speculative spike
9 Sep 2026Stock US$0.64 after -29.9% sessionSpike fades
Aug–Sep 2026Required for note tranche funding
23 Sep 20261-for-6 consolidation announcedNYSE American price compliance
7 Oct 2026Consolidation effective; pre-split last prices ~US$0.37–0.40~6x price reset

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

2 charts
Customer Share of Revenue (%): HAECO fell from 100% in FY2024 to 48.5% in FY2026.
Green Circle Decarbonize Technology Limited — Customer Share of Revenue (%)
Series (%)FY2024FY2025FY2026
HAECO10030.648.5
Macau University Hospital0046.9
LMP International051.34.6
SOAR Equipment Rental018.10

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. SEC EDGAR — Form 20-F for fiscal year ended 31 March 2026 (sec.gov)
  2. SEC EDGAR — Form 424(b)(4) IPO prospectus (12 Jan 2026) (sec.gov)
  3. SEC EDGAR — Form 424(b)(3) (Jan 2026) (sec.gov)
  4. SEC EDGAR — Form F-1 (Feb 2024) (sec.gov)
  5. SEC EDGAR — BF Borgers consent (Exhibit 23.1, F-1 2024) (sec.gov)
  6. SEC EDGAR — Form F-1 (2026 resale registration) (sec.gov)
  7. SEC EDGAR — DRS/A (2023) (sec.gov)
  8. SEC EDGAR — DRS/A (2023, management table) (sec.gov)
  9. SEC EDGAR — 6-K and Exhibit 99.1, share consolidation (23 Sep 2026) · sec.gov
  10. StockTitan — GCDT SEC filings index and summaries (6-K, 20-F, Form D) (stocktitan.net)
  11. StockTitan — 6-K interim results summary (stocktitan.net)
  12. StockTitan — 6-K CFO appointment (stocktitan.net)
  13. GlobeNewswire via Finviz — SANVO partnership (8 Sep 2026) (finviz.com)
  14. GlobeNewswire via Finviz — share consolidation (23 Sep 2026) (finviz.com)
  15. 10jqka (同花顺) — SANVO (HK0301) announcement (4 Sep 2026) (stock.10jqka.com.cn)
  16. StreetInsider — CFO appointment (streetinsider.com)
  17. Tiger Brokers / GlobeNewswire — CFO appointment (itiger.com)
  18. Manatt — IPO underwriter counsel announcement (manatt.com)
  19. Renaissance Capital — IPO pricing news and profile · renaissancecapital.com
  20. IPOScoop — company profile (iposcoop.com)
  21. Yahoo Finance — quotes (various dates) · ca.finance.yahoo.com · uk.finance.yahoo.com · de.finance.yahoo.com
  22. Benzinga — quote and aggregated financials (benzinga.com)
  23. Seeking Alpha — balance sheet summary (seekingalpha.com)
  24. MoneyDJ — company profile (moneydj.com)
  25. FXEmpire — company profile (fxempire.com)
  26. Weiss Ratings — filings/headlines summary (weissratings.com)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.